-transparent.png){kind=logo}
Human platelets contain fructose 2,6-bisphosphate, 6-phosphofructo-l-kinase (ATP: D-Fructose-6-phosphate-1-phosphotransferase, E.C.2.7. 1.11), the rate-limiting enzyme in platelet glycolysis appear to be significantly activated by physiological concentration of the compound, suggesting for fructose 2,6-bisphosphate a key regulatory role in the control of the glycolytic flux. Incubation of human platelets with thrombin results in a parallel and rapid increase of fructose-2,6-bisphosphate levels and glycolytic flux, suggesting that the compound may also be involved in the enhancement of glycolysis elicited by the stimulating agent.
Related Publications
M Farnararo, and
P Bruni, and
V Vasta
June 1993,
The Journal of biological chemistry,
M Farnararo, and
P Bruni, and
V Vasta
July 1987,
The Biochemical journal,
M Farnararo, and
P Bruni, and
V Vasta
June 1983,
Biochemical Society transactions,
M Farnararo, and
P Bruni, and
V Vasta
May 1986,
FEBS letters,
M Farnararo, and
P Bruni, and
V Vasta
January 1988,
Annals of the New York Academy of Sciences,
M Farnararo, and
P Bruni, and
V Vasta
September 1983,
Archives of biochemistry and biophysics,
M Farnararo, and
P Bruni, and
V Vasta
January 1993,
Advances in enzyme regulation,
M Farnararo, and
P Bruni, and
V Vasta
December 1985,
Archivos de biologia y medicina experimentales,
M Farnararo, and
P Bruni, and
V Vasta
June 1988,
Journal of biochemistry,
M Farnararo, and
P Bruni, and
V Vasta
August 1982,
The Biochemical journal,
